Relationship between chronic obstructive pulmonary disease and levels of vitamin D

Amaç: Vitamin D eksikliği, solunum fonksiyonlarında bozulma ile ilişkili olabilir. Çalışmamızda Kronik Obstruktif Akciğer Hastalığı (KOAH) hastalarında solunum fonksiyonları, hastalığın şiddeti ve alevlenme sıklığı ile serum Vitamin D düzeyi arasındaki ilişkiyi belirlemeyi amaçladık. Yöntemler: Polikliniğimize başvuran 70 KOAH hastası (GOLD Sınıflaması Evre II-IV) çalışmaya alındı. 30 sağlıklı gönüllü kontrol grubunu oluşturdu. Klinik bulgular ve solunum fonksiyon testine göre KOAH tanısı kondu. Serum 25-hidroksi vitamin D (25(OH)D) seviyesi immünofloresan yöntemi ile ölçüldü. 20 ng/mL altındaki değerler eksiklik olarak kabul edildi. Vitamin D düzeyi ile cinsiyet, yaş, Vücut Kitle İndeksi (VKİ), sigara içme durumu, komorbiditeler, alevlenme sıklığı arasındaki ilişki araştırıldı. Bulgular: Hasta grubunun yaş ortalaması 60,7 yıldı. Hastaları GOLD sınıflamasına göre ayırdığımızda %40’ı Evre II, %30’u Evre III, %30’u Evre IV KOAH’tı. Hasta ve kontrol grupları arasında serum 25(OH)D düzeyi bakımından anlamlı farklılık görülmedi. Vitamin D düzeyi kontrol grubunda 9,3 ±6,0 ng/mL, Evre II KOAH’da 9,7± 8,5 ng/mL, Evre III’te 9,6 ± 6,2 ng/mL ve Evre IV’te 5,1 ±2,4 ng/mL olarak belirlendi. Evre IV te Vitamin D düzeyi düşüklüğü istatistiksel olarak anlamlıydı (p=0.03). Hasta grubunda düşük FEV1, düşük 25(OH)D ile ilişkili bulundu (p=0.03). En sık görülen komorbidite hipertansiyon (%61,4) ve kalp yetmezliği idi (%27,1). Sigara içenlerde 25(OH)D düzeyi daha düşüktü (p=0,004). Son 12 aydaki alevlenme sıklığı ile serum 25(OH)D düzeyi düşüklüğü arasında ilişki saptandı (p=0.02). Sonuç: GOLD evrelemesine göre KOAH şiddeti ile 25(OH)D düzeyi düşüklüğü arasında ilişki vardır. Sigara içen KOAH hastalarında 25(OH)D düzeyi daha düşüktür. Ciddi Vitamin D eksikliği alevlenme sıklığında artış ile ilişkilidir. 25(OH)D düzeyi ile KOAH arasındaki ilişki, KOAH hastalarında Vitamin D düzeyini iyileştirmek gerektiğini düşündürmektedir.

Kronik obstruktif akciğer hastalığı ile vitamin D düzeyi arasındaki ilişki

Objective: Vitamin D deficiency may be associated with pulmonary function deterioration. The aim of this study is to assess the relationship of serum vitamin D levels with pulmonary functions, disease severity and exacerbation frequency in Chronic Obstructive Pulmonary Disease (COPD) patients. Methods: Seventy consecutive patients with COPD (Glob- al Initiative for Chronic Obstructive Lung Disease (GOLD) stage II-IV) who presented to our outpatient clinic and thirdty controls entered to the study. Diagnosis of COPD was confirmed according to clinical findings and pulmonary function test. Serum 25-hydroxyvitamin D (25(OH)D levels were measured by immunofluorescence method. Levels <20 ng/ mL defined deficiency. Associations between Vitamin D levels and sex, age, body mass index (BMI), smoking habit, comorbidities, exacerbation frequency were examined. Results: The mean age of patients was 60.7 years. The proportion of patients in stages 2 of GOLD was 40 %, in stages 3 was 30 % and stages 4was 30 %. There was no significant difference in serum levels of 25(OH)D between COPD patients and controls. Vitamin D level was 9.3 ±6.0 ng/mL in control group and 9.7± 8.5 ng/mL in GOLD stage 2, 9.6 ± 6.2 ng/mL in stage 3 and 5.1 ±2.4 ng/mL in stage 4. In stage 4, vitamin D levels was significantly lower statistically (p=0.03). Among the COPD patients, lower FEV1 was associated with lower levels of 25(OH)D (p= 0.03). The most frequent comorbidities were hypertension (61.4%) and heart failure (27.1%). Among the COPD patients smoking associated with significantly lower levels of serum 25(OH) D (p=0.04). We find an association with exacerbation frequency in the previous 12 months and levels of 25(OH) D (p=0.02). Conclusion: COPD severity according to GOLD stage is also associated with low levels of 25(OH)D. Serum vitamin D levels are lower in COPD patients who are current smokers. Severe vitamin D deficiency is related to more frequent disease exacerbations. These findings indicated a relationship between serum 25(OH)D concentrations and COPD which suggests optimization of serum vitamin D levels in COPD.

___

  • 1. Holick MF.Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
  • 2. Cosio BG, Agusti A. Update in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 181:655- 660.
  • 3. Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164: 2405-2411.
  • 4. Lemire JM, Adams JS, Kermani-Arab V, et al. 1,25-Dihy- droxyvitamin D3 suppresses human T helper/inducer lym- phocyte activity in vitro. J Immunol 1985; 134:3032-3035.
  • 5. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.
  • 6. Hansdottir S, Monick MM, Hinde SL, et al. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008; 181:7090-7099.
  • 7. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2008; 57:847-852.
  • 8. Schlaich C, Minne HW, Bruckner T, et al. Reduced pulmonary function in patients with spinal osteoporotic fractures. Osteoporos Int 1998; 8:261-267.
  • 9. Dursun A. D vitamininin kemik metabolizması dışındaki etkileri. Beslenmede Yenilikler I-II, Katkı Pediatri Dergisi 2007; 28:225-234.
  • 10. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory dam- age in chronic disorders? QJM 2002; 95:787-796.
  • 11. Banerjee A, Panettieri RJr. Vitamin D modulates airway smooth muscle function in COPD. Curr opin Pharmacol 2012
  • 12. Wright RJ. Make no nounes about it: epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005;128: 3871-3873.
  • 13. Sundar IK, Rahman I. Vitamin D and susceptibility of chronic lung disease: role of epigenetics. Front Pharmacol 2011; 2:50.
  • 14. Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis. Clin Exp Allergy 2009; 39:875-882.
  • 15. Janssens W, Bouillon R, Claes B, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65:215-220.
  • 16. Janssens W, Mathieu C, Boonen S, Decramer M. Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. Vitam Horm 2011; 86:379-99.
  • 17. Heulens N, Decramer M, Janssens W. Severe vitamin D deficiency: a biomarker of exacerbation risk? Am J Respir Crit Care Med. 2013; 187:214-215.
  • 18. Holick MF.Vitamin D deficiency. N Engl J Med 2007; 357:266-281.
  • 19. Murray CJ, Lopez AD. Alternative projections of mortality- and disability by cause 1990-2020: Global Burden of Disease Study.Lancet 1997; 349:1498-1504.
  • 20. Strassels SA, Smith DH, Sullivan SD, Mahajan PS.The costs of treating COPD in the United States. Chest 2001;119:344-352.
  • 21. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD, 2015 (update) www.goldcopd.com.
  • 22. Norman AW, Bouillon R, Whiting SJ, et al. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 2007; 103:204-205.
  • 23. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16:713- 716.
  • 24. Alagöl F, Shihadeh Y, Boztepe H, et al. Sunlight exposure and vitamin D deficiency in Turkish Women. J Endocrinol Invest 2000; 23:173-177.
  • 25. Pehlivan İ, Hatun Ş, Aydoğan M, et al. Maternal serum vitamin D levels in the third trimester of pregnancy. Turk J Med Sci 2002; 32:237-241.
  • 26. Malabanan A, Veronikis IE, Holick MF.Redefining vitamin D insufficiency.Lancet 1998; 351:805-806.
  • 27. Vitamin D: extraskeletal health.Holick MF. Rheum Dis Clin North Am. 2012 Feb; 38:141-160.
  • 28. Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE. Vitamin D status and longitudinal lung function decline in the Lung Health Study. Eur Respir J 2011; 37:238-243.
  • 29. Black PN, Scragg R. Relationship between serum 25-hy- droxyvitamin D and pulmonary function in the third national health and nutrition examination survey.Chest 2005; 128:3792-3798.
  • 30. Ringbaek T, Martinez G, Durakovic A, et al. Vitamin D status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. J Cardiopul- monary Rehab Prevention 2011; 31:261-267.
  • 31. Franco CB, PazFillho G, Gomes PE, et al. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009;20:1881- 1887.
  • 32. Persson LJP, Aanerud M, Hiemstra PS, et al. COPD is as- sociated with low levels of vitamin D. PLoS One 2012;7:6.
  • 33. Celli BR, MacNee W. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946.
  • 34. Semba RD, Chang SS, Sun K, et al.Serum 25-Hydroxyvi- tamin D and Pulmonary Function in Older Disabled Community-Dwelling Women. J Gerontol A Biol Sci Med Sci 2012; 67:683-689.
  • 35. Shaheen SO, Jameson KA, Robinson SM, et al.Relationship of vitamin D status to adult lung function and COPD. Thorax 2011; 66:692-698.
  • 36. Ampikaipakan SN, Hughes DA, Hughes JC, et al. Vitamin D and COPD: seasonal variation is important. Thorax 2011; 66:541-542.
  • 37. Jenkins CR, Celli B, Anderson JA, et al. Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.Eur Respir J. 2012; 39:38-45.
  • 38. Lange NE, Sparrow D, Vokonas P, Litonjua AA.Vitamin D deficiency, Smoking, and Lung Function in the Normative Aging Study. Am J Respir Crit Care Med. 2012 Oct 1; 186:616-621.
  • 39. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Exp Immunol 2009; 158:20-25.
  • 40. Lee JH, O’Keefe JH, Bell D. Vitamin D deficiency an im- portant, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
  • 41. Forman JP, Williams JS, Fisher ND.Plasma 25-hydroxyvitamin D and regulation of the renin angiotensin system in humans. Hypertension 2010; 55:1283-1288.
  • 42. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bio- availability of vitamin D in obesity. Am J Clin Nutr 2000; 72:690-693.
  • 43. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and Diabetes. Diabetologia 2005; 48:1247-1257.
  • 44. McGill AT, Stewart JM, Lithander FE, et al. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 28:4-7.
  • 45. Agusti A, Soriano JB.COPD as a systemic disease. COPD 2008; 5:133-138.
  • 46. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle crosssectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:809- 813.
  • 47. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134: 1129-1140.
  • 48. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909- 2912.
  • 49. Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012; 156:105-114.
Dicle Tıp Dergisi-Cover
  • ISSN: 1300-2945
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1963
  • Yayıncı: Cahfer GÜLOĞLU
Sayıdaki Diğer Makaleler

Fetal interrupted aortik ark tip B’nin antenatal değerlendirilmesi

Ali BABACAN, Yaşam AKPAK, Okan ÖZDEN, Selami SÜLEYMANOĞLU, Ersin ÖZTÜRK, Ercüment MÜNGEN

Neovasküler tip yaşa bağlı makula dejenerasyonunda intravitreal ranibizumab uygulamalarında tedavi etkinliği ve rekürrens üzerinde etkili olan faktörler

Özlem KURU, Burak ERDEN, Mustafa Nuri ELÇİOĞLU

Kronik obstruktif akciğer hastalığı ile vitamin D düzeyi arasındaki ilişki

Buket ÇİLİNGİR, Hülya GÜNBATAR

Sigmoid aktivasyon fonksiyonu kestirimi kullanılarak karaciğer hastalığı tanısında çok katmanlı sinir ağı uygulaması

Onursal ÇETİN, Feyzullah TEMURTAŞ, Şenol GÜLGÖNÜL

Astımda semptom kontrolü ve yaşam kalitesi ilişkisi

NURGÜL BOZKURT, Ali İhsan BOZKURT

Skin prick test results of atopic asthmatic subjects in a chest disease clinic in Sanliurfa

İbrahim KOÇ, Yusuf DOĞAN, Serdar DOĞAN, Zeynel Abidin KARATAŞ

Vücut kompozisyon parametreleri ile nonalkolik hepatosteatoz ilişkisi

Mesut SİPAHİ, Halil SERİN, Mustafa ERKOÇ, Çiğdem KANTEKİN, Ergin ARSLAN, Hasan BÖREKÇİ

An application of multilayer neural network on hepatitis disease diagnosis using approximations of sigmoid activation function

ONURSAL ÇETİN, FEYZULLAH TEMURTAŞ, Şenol GÜLGÖNÜL

Skin prick test results of atopic asthmatic subjects in a chest disease clinic in Sanliurfa Şanlıurfa’da bir göğüs hastalıkları kliniğinde atopik astımlı hastaların allerji deri testi sonuçları

İbrahim KOÇ, Yusuf DOĞAN, Serdar DOĞAN, Zeynel KARATAŞ

Adölesan amatör futbolcularda görülen spina iliaka anterior ve superior avulsiyon kırıklarının konservatif tedavisi: İki olgu sunumu

Umut Hatay GÖLGE, Burak KAYMAZ, Ferdi GÖKSEL, Ersin KUYUCU, Erkam KÖMÜRCÜ